GlaxoSmithKline plc using EPIC/TICKER code (LON:GSK) has had its stock rating noted as ‘Downgrades’ with the recommendation being set at ‘NEUTRAL’ today by analysts at UBS. GlaxoSmithKline plc are listed in the Health Care sector within UK Main Market. UBS have set a target price of 1650 GBX on its stock. This would imply the analyst believes there is now a potential upside of 8.4% from the opening price of 1522 GBX. Over the last 30 and 90 trading days the company share price has increased 46.8 points and decreased 60 points respectively. The 52 week high for the share price is currently at 1648.8 GBX while the year low share price is currently 1179.39 GBX.
GlaxoSmithKline plc has a 50 day moving average of 1,522.61 GBX and a 200 day moving average of 1,544.31. There are currently 4,964,922,506 shares in issue with the average daily volume traded being 8,475,717. Market capitalisation for LON:GSK is £75,963,314,341 GBP.